Background illustration for clinical trials search

Paid Clinical Trials California

Discover 5,800 paid clinical trials in California. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

for
Coronary Artery Disease Risk Factors Multiple,
Location: Boston MA, New York NY, Charlottesville VA, Durham NC,
Sponsor: Duke University

Sex: All

Age: 30 - 60

Code: NCT07232069

Phase 3, Recruiting
Active & Responsive

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

for
Age-Related Macular Degeneration,
Location: Manchester CT, Beachwood OH, Lemont IL, Tyler TX,
Sponsor: i-Lumen Scientific AUS PTY LTD

Sex: All

Age: 60+

Code: NCT06662162

Recruiting
Active & Responsive

Randomized Controlled Trial of the STEIN Protocol: A Neuroplastic Pain Education and Guided Breathing Intervention During Awake Cataract Surgery

for
Cataract, Cataract (Post-operative Cataract Surgery Follow-up)
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 0+

Code: NCT07715591

Recruiting
Active & Responsive

Neonatal White Matter Injury Trial (WRAP)

for
White Matter Injury, Brain Injury, Fetus and Neonate,
Location: San Francisco CA
Sponsor: Bridget LaMonica Ostrem, M.D., Ph.D.

Sex: All

Age: 0

Code: NCT07688746

Phase 1, Recruiting
Active & Responsive

A Study of MZE782 in Adults With PKU

for
Phenylketonuria (PKU)
Location: Gordonville PA, Lexington KY, Indianapolis IN,
Sponsor: Maze Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07694440

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.

for
Stomatitis
Location: Wynnewood PA, East Syracuse NY, Fairfax VA, Wilson NC,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07357597

Phase 4, Recruiting
Active & Responsive

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

for
Lymphoma, Non-Hodgkin, B-cell Lymphoma,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07101328

Phase 1, Recruiting
Active & Responsive

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

for
Clear Cell Renal Cell Cancer (ccRCC),
Location: San Francisco CA
Sponsor: Kelly Fitzgerald, MD

Sex: All

Age: 18+

Code: NCT07043608

Phase 2, Recruiting
Active & Responsive

Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients

for
Stroke, Hemorrhagic Stroke
Location: New York NY, Jacksonville FL, Houston TX,
Sponsor: EMVision Medical Devices Ltd

Sex: All

Age: 22+

Code: NCT06999122

Recruiting
Active & Responsive

SONATA LIFU for OCD

for
Obsessive Compulsive Disorder
Location: San Francisco CA
Sponsor: University of Pennsylvania

Sex: All

Age: 22 - 70+

Code: NCT07728994

Phase 2, Recruiting
Active & Responsive

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

for
Colorectal Cancer
Location: New York NY, East Brunswick NJ, Fairfax VA,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07659795

Phase 2, Recruiting
Active & Responsive

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

for
Unresectable or Metastatic Hepatocellular Carcinoma,
Location: Boston MA, Atlanta GA, Peoria IL, Orange CA, Irvine CA,
Sponsor: CatalYm GmbH

Sex: All

Age: 18 - 70+

Code: NCT07219459

Phase 2, Recruiting
Active & Responsive

A Study of ARC-02 in B-cell NHL

for
B-cell Non Hodgkin Lymphoma
Location: Spokane WA, Los Angeles CA
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07691606

Phase 1, Recruiting
Active & Responsive

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

for
Graves' Disease, Graves Disease
Location: New York NY, Albany NY, Raleigh NC, Fort Lauderdale FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07570316

Phase 3, Recruiting
Active & Responsive

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

for
Alzheimer Disease
Location: Watertown MA, Methuen MA, Albany NY, Aventura FL,
Sponsor: Alpha Cognition, Inc

Sex: All

Age: 50+

Code: NCT07633470

Phase 4, Recruiting
Active & Responsive

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

for
Lung Non-Small Cell Carcinoma
Location: Bath ME, Brunswick ME, Portland ME, Scarborough ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07293247

Phase 2, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension
Location: New Hyde Park NY, New York NY, Philadelphia PA,
Sponsor: Insmed Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07481981

Phase 3, Recruiting
Active & Responsive

A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy

for
Epileptic Encephalopathy
Location: Boston MA, Columbus OH, Orange CA
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 2 - 12

Code: NCT07227857

Phase 1, Phase 2, Recruiting
Active & Responsive

Preventing Medication Mismanagement in People Living With Dementia

for
Dementia
Location: Folsom CA
Sponsor: HiDO Technologies

Sex: All

Age: 65+

Code: NCT07600684

Recruiting
Active & Responsive

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

for
Hyperphosphatemia,
Location: Orange CT, Middlebury CT, Ridgewood NY, Norfolk VA,
Sponsor: R1 Therapeutics

Sex: All

Age: 18+

Code: NCT06712654

Phase 2, Recruiting

Popular cities in California

With its extensive healthcare system and world-class medical research institutions, California is a major hub for clinical trials. Leading research centers such as UCLA Health, Stanford Medicine, the University of California, the City of Hope, San Francisco (UCSF), and the Scripps Research Institute are spearheading medical research and innovation. These institutions are at the cutting edge of clinical studies, driving advancements in groundbreaking treatments and significantly contributing to healthcare innovations across the state.

Why choose California for clinical trials?

The state of California offers a variety of benefits for participants in clinical trials. Firstly, because the state is home to leading research institutions, it provides participants with access to cutting-edge treatments and advanced medical technologies before they become widely available. These institutions are equipped with state-of-the-art facilities and staffed by top experts, ensuring high-quality care and rigorous monitoring throughout the study.

California's diverse and innovative research landscape offers a wide range of study options, enhancing the likelihood of finding a trial that matches specific health needs. Moreover, the state's adherence to stringent regulatory and ethical standards ensures that trials are conducted with the utmost integrity and participant protection.

Common conditions studied in California

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in California